InventorsUS Classes424/209.1, Orthomyxoviridae (e.g., influenza virus, fowl plague virus, etc.)546/118, Three ring nitrogens in the bicyclo ring system514/303, Exactly three ring nitrogens in the bicyclo ring system514/293, Three or more hetero atoms in the tricyclo ring system546/82, Three or more ring hetero atoms in the tricyclo ring system424/184.1, ANTIGEN, EPITOPE, OR OTHER IMMUNOSPECIFIC IMMUNOEFFECTOR (E.G., IMMUNOSPECIFIC VACCINE, IMMUNOSPECIFIC STIMULATOR OF CELL-MEDIATED IMMUNITY, IMMUNOSPECIFIC TOLEROGEN, IMMUNOSPECIFIC IMMUNOSUPPRESSOR, ETC.)424/234.1, Bacterium or component thereof or substance produced by said bacterium (e.g., Legionella, Borrelia, Anaplasma, Shigella, etc.)424/204.1Virus or component thereofAttorney, Agent or FirmInternational ClassesA61K 39/145C07D 471/04 A61K 31/437 A61K 31/4375 C07D 471/14 A61P 31/12 A61P 31/04 A61K 39/00 A61K 39/02 A61K 39/12 Issued Patent Number:8063063Abstract textThe invention provides novel compositions comprising Imidazopyridine compounds. Also provided are methods of administering the compositions in an effective amount to enhance the immune response of a subject. Further provided are novel compositions and methods of administering the compositions in combination with (an)other agent(s). |
| ||||||||||||||